Doron Therapeutics
PrivateLast Round
Series A
Nov 25, 2024
Total Funding Raised
$11M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Doron Therapeutics is a clinical-stage biotechnology company developing biologic therapies for osteoarthritis. The company's lead product, MOTYS™, is a Phase 3-ready intra-articular biologic drug derived from placental tissue designed to treat knee osteoarthritis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Doron Therapeutics Comparables
Compare Doron Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genascence Corporation | 83% | |
| 4Moving Biotech | 82% | |
| Levicept | 81% |
Doron Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 25, 2024 |
Doron Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SPRIM Global Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 174% MoM.
- Oct 16, 2025
Doron Therapeutics, a clinical-stage biotechnology company, is developing novel biologics for musculoskeletal diseases.
Doron Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Doron Therapeutics's valuation, stock price, and market status.
Is Doron Therapeutics a public or private company?
Doron Therapeutics is a private company.
What is the current stock price of Doron Therapeutics?
Doron Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Doron Therapeutics worth (valuation)?
Valuation information for Doron Therapeutics is not publicly available.
Can I buy Doron Therapeutics stock?
Doron Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Doron Therapeutics's last funding round?
Doron Therapeutics's most recent funding round was Series A on November 25, 2024.
Who are the main investors in Doron Therapeutics?
Key investors in Doron Therapeutics include SPRIM Global Investments.
Will Doron Therapeutics IPO soon?
No public IPO plans have been announced for Doron Therapeutics.
How can I track Doron Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Doron Therapeutics's secondary market activity and sign up for updates.